Immune checkpoint inhibitor induced large vessel vasculitis.

ABSTRACT: This is a case report of a 67-year-old patient with castration resistant metastatic prostate cancer who developed an immune-mediated large vessel vasculitis following treatment with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1).

SUBMITTER: Henderson D 

PROVIDER: S-EPMC7239530 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature